Created at 2:40 p.m. Sep, 19, 2025
Author: Karimycheese
Related Note: 1551143620883 5
Rationale for change

ADA recommendation: https://diabetesjournals.org/care/article/46/Supplement_1/S158/148038/10-Cardiovascular-Disease-and-Risk-Management

This change reflects current ADA and clinical guidelines, which recommend moderate-intensity statins for all diabetes patients aged 40 to 75, regardless of their estimated 10-year ASCVD risk. High-intensity statins are reserved for patients with additional ASCVD risk factors or very high cardiovascular risk, rather than for all patients with diabetes and just a 10-year ASCVD risk >7.5%
Source: Society Guidelines - https://arc.net/l/quote/cfgrxwht

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
#AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::cholesterol #AK_Other::AnKing_Image::Mujeeb::Statin_use_in_adults #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::07_Drugs_for_Hyperlipidemia #AK_Step2_v12::#AMBOSS::nsa7vN #AK_Step2_v12::Original_decks::Dorian::im::uw::cardio #AK_Step2_v12::#SketchyIM::01_Cardiology::04_Dyslipidemia::01_Dyslipidemia:_Ambulatory_Concerns #AK_Step2_v12::#NinjaNerd::04_Pharmacology::01_Basics::07_Drugs_for_Hyperlipidemia #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::15_HMG-CoA_Reductase_Inhibitors_(Statins) #AK_Other::AnKing_Image::!Subjects::Cardiology::Statin_use_in_adults #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::08_Cholesterol #AK_Step2_v12::#AMBOSS::DCa185 #AK_Step2_v12::#Resources_by_rotation::IM::uw::cardio::cardio_dorian #AK_Step2_v12::#Resources_by_rotation::tests_dorian::nbme6 #PANCE::CARDIO::coronary_artery_disease #AK_Other::Card_Features::^One_By_One #AK_Step2_v12::#NBME::Form12 #AK_Step2_v12::#AMBOSS::PG0Wzh #AK_Step3_v12::#UWorld::5024 #AK_Step2_v12::#B&B::02_Cardio::06_Other::03_Hyperlipidemia #AK_Step2_v12::#SketchyIM::01_Cardiology::01_Ischemic_Heart_Disease::09_Post_ACS_Management #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::#AMBOSS::b80HO3 #AK_Step2_v12::#SketchySurgery::01_Preoperative_&_Postoperative_Surgical_Considerations::01_Preoperative::01_Cardiac_Risk_Assessment_and_Perioperative_Management #AK_Step2_v12::#CMS::FM::Form_03 #PANCE::EOR::Family_med #AK_Step2_v12::#Bootcamp::Medicine::01_Cardiology::01_Coronary_Artery_Disease::08_Cardiovascular_Disease_Risk_Assessment #AK_Step2_v12::#OME::06_Surgery::03_Surgical_Subspecialties::08_Vascular #AK_Step2_v12::#UWorld::Step::3822 #AK_Step2_v12::Original_decks::Dorian::step2::nbme6 #AK_Step2_v12::#SketchyFM::02_Chronic_Diseases::01_Cardiovascular::01_Hyperlipidemia:_Ambulatory_Concerns #AK_Step2_v12::#UWorld::Step::17515 #AK_Other::Only_Step_2 #PANCE::EOR::Surgery #AK_Step2_v12::#Resources_by_rotation::FM::ome::cardio::cholesterol #AK_Step2_v12::#SketchyIM::01_Cardiology::12_Retired_Lessons::01_Ischemic_Heart_Disease::03_Acute_Coronary_Syndromes_SOA_[OLD_VERSION] #AK_Step2_v12::#AMBOSS::1Fa2Sm #AK_Step2_v12::#SketchyIM::01_Cardiology::02_Heart_Failure::06_Chronic_Heart_Failure_Management_Part_1 #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::09_Statins #PANCE::EOR::EM #AK_Step2_v12::#NinjaNerd::06_Cardiovascular::03_Pathology::13_Hyperlipidemia #AK_Step2_v12::#UWorld::COMLEX::100616 #AK_Step2_v12::#NBME::Form11::Section_2 #AK_Step2_v12::#Subjects::Cardiology::08_Cholesterol::Management #AK_Step2_v12::#SketchyIM::01_Cardiology::12_Retired_Lessons::01_Ischemic_Heart_Disease::02_Ischemic_Chest_Pain_Intro_&_Stable_Angina_SOAP_[OLD_VERSION #AK_Step2_v12::Original_decks::Dorian::im::ome::cardio::cholesterol #AK_Step2_v12::#CMS::IM::Form_08 #PANCE::EOR::IM #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#SketchyIM::01_Cardiology::01_Ischemic_Heart_Disease::05_Unstable_Angina/NSTEMI #AK_Step2_v12::#FirstAid::01_Cardiovascular::09_Dyslipidemia::01_Dyslipidemia #AK_Step2_v12::#AMBOSS #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::02_Diabetes_Complications::Extra #AK_Step2_v12::Original_decks::Dorian::fam::ome::cardio::cholesterol #AK_Step2_v12::#OME::Clinical::01_Medicine::01_Cardiology::08_Cholesterol #AK_Step1_v12::#Bootcamp::Biochemistry::09_Lipid_Metabolism::09_Hyperlipidemia_Pharmacology